Skip to main content
NewslettersWatchlist

Inmed Pharmaceuticals Inc(INM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Inmed Pharmaceuticals Inc

SUITE 310 815 W. HASTINGS STREET
VANCOUVER A1 V6C 1B4 CAN
P: 604-669-7207
F: 778-945-6800
http://www.inmedpharma.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

    Key Executives

    NameTitle
    N. Netta JagpalCFO/Chief Accounting Officer/Secretary

    More from The Globe

    Premarket: Global stocks rally on rate cut hopes
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 15, 2024. REUTERS/Brendan McDermid
    Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
    Shopify offices in Toronto on May 13, 2024. May 13, 2024. (Sammy Kogan/The Globe and Mail)
    The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
    Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
    Chevron tops Tesla as most-shorted stock in April, says Hazeltree
    The Chevron Pascagoula Refinery is pictured in Pascagoula, Mississippi on Sept. 4, 2018.
    The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
    The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
    Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation
    Kaz Nejatian, COO of Shopify, speaks at the Collision conference in Toronto, Wednesday, June 28, 2023. THE CANADIAN PRESS/Chris Young
    How pro money managers are balancing exposure to Canadian and U.S. stocks
    Rob Carrick

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.